BIOVIE INC.

Develops drug therapies for Alzheimer's, Parkinson's, and advanced liver diseases by targeting inflammation.

BIVI | NDAQ

Overview

Corporate Details

ISIN(s):: US09074F4054
LEI:
Country:: United States of America
Address:: 680 W NYE LANE, 89703 CARSON CITY
Website:: https://www.bioviepharma.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioVie Inc. is a clinical-stage biopharmaceutical company developing innovative drug therapies for chronic debilitating conditions, with a primary focus on neurological, neurodegenerative, and advanced liver diseases. The company's scientific approach posits that inflammation is a central factor in the progression of these disorders. Its lead therapeutic candidate, bezisterim, is a novel molecule being studied for the treatment of Alzheimer's and Parkinson's disease, aiming to modulate inflammation and enhance brain energy transfer. BioVie is also developing treatments for ascites, a common and life-threatening complication of advanced liver cirrhosis. The company's research incorporates advanced science, including the study of epigenetic mechanisms like DNA methylation to regulate gene expression.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIOVIE INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOVIE INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BIOVIE INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
CervoMed Inc. Developing CNS therapeutics for neurodegenerative diseases like dementia with Lewy bodies.	United States of America	CRVO
Cessatech A/S Develops a non-invasive nasal spray for acute pain relief in children during medical procedures.	Denmark	CESSA
CG Invites Co., Ltd. Biopharma advancing precision medicine with drugs, mRNA vaccines, and digital therapeutics.	South Korea	083790
CG Oncology, Inc. Developing bladder-sparing oncolytic immunotherapies for patients with bladder cancer.	United States of America	CGON
CHA Vaccine Research Institute Develops vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.	South Korea	261780
CHEIL BIO CO., LTD. Manufactures veterinary medicines and feed additives for livestock, aquatic animals, and pets.	South Korea	052670
Chemical Works of Gedeon Richter Plc Develops and manufactures drugs for women's health, CNS, and cardiovascular diseases.	Hungary	RICHT
Chemomab Therapeutics Ltd. Develops antibody drugs neutralizing CCL24 for severe fibro-inflammatory diseases.	United States of America	CMMB
CHINA PHARMA HOLDINGS, INC. Develops, manufactures, and sells prescription, OTC, and nutritional products for human use.	United States of America	CPHI
China SXT Pharmaceuticals, Inc. Researches, produces, and sells advanced Traditional Chinese Medicine (TCM) herbal products.	United States of America	SXTC